Tolectin (TOLMETIN SODIUM)
Tolectin (TOLMETIN SODIUM) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Tolectin; Generic name: TOLMETIN SODIUM; Manufacturer: Poly Pharmaceuticals, Inc..
| Brand name | Tolectin |
|---|---|
| Generic name | TOLMETIN SODIUM |
| Manufacturer | Poly Pharmaceuticals, Inc. |
| Used for | INDICATIONS & USAGE Carefully consider the potential benefits and risks of TOLECTIN tablets, USP and other treatment options before deciding to use TOLECTIN tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). TOLECTIN tablets are indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis. TOLECTIN tablets are indicated in the treatment of acute flares and the long-term management of the chronic disease. TOLECTIN tablets are also indicated for treatment of juvenile rheumatoid arthritis. The safety and effectiveness of TOLECTIN tablets have not been established in pediatric patients |
| Dosage | DOSAGE & ADMINISTRATION Carefully consider the potential benefits and risks of TOLECTIN and other treatment options before deciding to use TOLECTIN. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). After observing the response to initial therapy with TOLECTIN, the dose and frequency should be adjusted to suit an individual patient’s needs. For the relief of rheumatoid arthritis or osteoarthritis, the recommended starting |
| Warnings | WARNINGS Cardiovascular Effects Cardiovascular Thrombotic Events Clinical trials of several COX-2 selective and nonselective NSAIDs of up to 3 years duration have shown an increased risk of serious cardiovascular (CV) thrombotic events, including myocardial infarction (MI) and stroke, which can be fatal. Based on available data, it is unclear that the risk for CV thrombotic events is similar for all NSAIDs. The relative increase in serious CV thrombotic events over baseline conferred by NSAID us |
| Active ingredient(s) | TOLMETIN SODIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15467b19-e43a-5be9-e063-6294a90a3cca |